ISDA

Deposition Date 2013-01-30

Release Date 2013-12-18

Last Version Date 2023-09-20

Entry Detail

PDB ID:

4IZY

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.26

R-Value Work:

0.23

R-Value Observed:

0.23

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase 8
Chain IDs:A
Chain Length:369
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P45983 Pfam ID:PF00069

Protein Blast

Polymer Type:polypeptide(L)
Molecule:C-Jun-amino-terminal kinase-interacting protein 1
Gene (Uniprot):MAPK8IP1
Chain IDs:B
Chain Length:11
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q9UQF2

Ligand Molecules

1J2

Primary Citation

Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.

Gong, L, Han, X, Silva, T, Tan, Y.C, Goyal, B, Tivitmahaisoon, P, Trejo, A, Palmer, W, Hogg, H, Jahagir, A, Alam, M, Wagner, P, Stein, K, Filonova, L, Loe, B, Makra, F, Rotstein, D, Rapatova, L, Dunn, J, Zuo, F, Dal Porto, J, Wong, B, Jin, S, Chang, A, Tran, P, Hsieh, G, Niu, L, Shao, A, Reuter, D, Hermann, J, Kuglstatter, A, Goldstein, D.Show

Bioorg.Med.Chem.Lett. 23 3565 3569 (2013)

PMID: 23664880 DOI: 10.1016/j.bmcl.2013.04.029

Abstact

A novel series of indole/indazole-aminopyrimidines was designed and synthesized with an aim to achieve optimal potency and selectivity for the c-Jun kinase family or JNKs. Structure guided design was used to optimize the series resulting in a significant potency improvement. The best compound (17) has IC50 of 3 nM for JNK1 and 20 nM for JNK2, with greater than 40-fold selectivity against other kinases with good physicochemical and pharmacokinetic properties.

Legend

Protein

Chemical

Disease

Primary Citation of related structures